Eitemau Tebyg: Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions
- Lyrica Case Study: Building a Successful Drug Launch Strategy
- Topamax, Femara, & Torcetrapib Case Study: Utilizing Usage Extension to Broaden a Drug's Patient Base
- Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
- Osteoporosis Drug Reformulation Case Study: Refreshing a Brand Through Reformulation
- GlaxoSmithKline Case Study: Switching Drugs to OTC Status Effectively
- GSK, Wyeth & Forest Laboratories Case Study: Prolonging a Drug's Lifecycle in the Antidepressant Market